Eckert & Ziegler BEBIG appoints new Members to the Board of Directors
(Thomson Reuters ONE) -
Seneffe, 11 June 2012 - Today Susanne Becker and Dr. Michael Friebe were elected
as new Members to the Eckert & Ziegler BEBIG Board of Directors at its Annual
Shareholders' Meeting. They are replacing outgoing members Holger Bürk, Hans-
Jörg Hinke, Dick Schoolenberg und Edwin Vandermeulen as the size of the Board of
Directors is being reduced to eight members.
Susanne Becker is an attorney and works as an advisor in the Labor Market
Division of the Confederation of German Employers' Associations in Berlin (BDA).
Dr. Friebe is Managing Director of m2f investment, a venture capital company for
start-ups in the life sciences sector, as well as id+tm, a consulting company
that specializes in medical technology. For almost 20 years in his capacity as
founder and investor, he has started numerous companies in the field of medical
imaging. In addition, Dr. Friebe is Chairman of the Supervisory Board of
SurgicEye GmbH and an Advisory Board Member of Curefab GmbH in Munich, as well
as a lecturer at the Technical University Munich.
"On behalf of the Board of Directors, I would like to thank the outgoing members
for their faithful and committed service during the last years. We would also
like to welcome the new Members to the Board of Directors and look forward to a
successful collaboration," said Dr. Andreas Eckert, Chairman of the Board of
Directors.
About Eckert & Ziegler BEBIG
Contributing to saving lives!
Eckert & Ziegler BEBIG is a European-based group active in the medical device
segment of the health care industry. Its core business is the treatment of
cancer using brachytherapy, a special form of radiation therapy.
Eckert & Ziegler BEBIG is a leader in brachytherapy in Europe. The company
headquarters are in Belgium, with a production facility in Germany and
subsidiaries throughout Europe and in India. In addition, Eckert & Ziegler BEBIG
has a worldwide network of distributors and agents to support the international
marketing of its product line.
The company's products and equipment are intended for use by oncologists,
radiologists, urologists, and medical physicists.
Eckert & Ziegler BEBIG employs more than 150 people. The company has been listed
on the Euronext stock exchange since April 1997 (Euronext: EZBG; Reuters:
EZBG.BR; Bloomberg: EZBG:BB).
For further information, please contact:
Karolin Riehle, Investor Relations
Tel.: +32 (0) 64 520 808, ir(at)bebig.eu, www.bebig.eu
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Eckert & Ziegler BEBIG via Thomson Reuters ONE
[HUG#1618789]
Unternehmensinformation / Kurzprofil:
Datum: 11.06.2012 - 17:42 Uhr
Sprache: Deutsch
News-ID 155196
Anzahl Zeichen: 3270
contact information:
Town:
Seneffe
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 473 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Eckert & Ziegler BEBIG appoints new Members to the Board of Directors"
steht unter der journalistisch-redaktionellen Verantwortung von
Eckert & Ziegler BEBIG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
